🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Cardiol Therapeutics Inc. (TSX:CRDL)
Canada flag Canada · Delayed Price · Currency is CAD
1.250
-0.110 (-8.09%)
Nov 19, 2026, 4:00 PM EST

Cardiol Therapeutics Statistics

Total Valuation

TSX:CRDL has a market cap or net worth of CAD 146.03 million. The enterprise value is 116.90 million.

Market Cap146.03M
Enterprise Value 116.90M

Important Dates

The next estimated earnings date is Thursday, November 19, 2026.

Earnings Date Nov 19, 2026
Ex-Dividend Date n/a

Share Statistics

TSX:CRDL has 116.82 million shares outstanding. The number of shares has increased by 33.16% in one year.

Current Share Class 116.82M
Shares Outstanding 116.82M
Shares Change (YoY) +33.16%
Shares Change (QoQ) +2.69%
Owned by Insiders (%) 2.99%
Owned by Institutions (%) 21.50%
Float 97.73M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 5.76
P/TBV Ratio 5.76
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.26, with a Debt / Equity ratio of 0.00.

Current Ratio 6.26
Quick Ratio 5.66
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -201.47% and return on invested capital (ROIC) is -118.59%.

Return on Equity (ROE) -201.47%
Return on Assets (ROA) -96.76%
Return on Invested Capital (ROIC) -118.59%
Return on Capital Employed (ROCE) -128.27%
Weighted Average Cost of Capital (WACC) 7.84%
Revenue Per Employee n/a
Profits Per Employee -2.08M
Employee Count18
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -9.86% in the last 52 weeks. The beta is 0.65, so TSX:CRDL's price volatility has been lower than the market average.

Beta (5Y) 0.65
52-Week Price Change -9.86%
50-Day Moving Average 1.90
200-Day Moving Average 1.82
Relative Strength Index (RSI) 27.11
Average Volume (20 Days) 88,599

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -35.48M
Pretax Income -37.44M
Net Income -37.44M
EBITDA -35.46M
EBIT -35.48M
Earnings Per Share (EPS) -0.34
Full Income Statement

Balance Sheet

The company has 29.23 million in cash and 97,274 in debt, with a net cash position of 29.13 million or 0.25 per share.

Cash & Cash Equivalents 29.23M
Total Debt 97,274
Net Cash 29.13M
Net Cash Per Share 0.25
Equity (Book Value) 27.60M
Book Value Per Share 0.23
Working Capital 27.52M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -21.70 million and capital expenditures -78,309, giving a free cash flow of -21.78 million.

Operating Cash Flow -21.70M
Capital Expenditures -78,309
Depreciation & Amortization 13,033
Net Borrowing -55,376
Free Cash Flow -21.78M
FCF Per Share -0.19
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TSX:CRDL does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -33.16%
Shareholder Yield -33.16%
Earnings Yield -27.59%
FCF Yield -13.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2